证券记录 · 已归档季度
HAE
Haemonetics Corporation · Healthcare · Medical - Devices
19被追踪持有人
0Δ持有人
21.92M持有股份
$1.07B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 0.0% · 净新建仓位 -5.3% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 467.31K | $49.40M | n/a | −2 |
| Q2 2026 | 104 | -6 | 39.44M | $2.63B | +3 | −11 |
| Q1 2026 | 115 | +1 | 38.93M | $1.98B | +9 | −9 |
| Q4 2025 | 115 | -1 | 49.79M | $3.32B | +2 | −2 |
| Q3 2025 | 19 | 0 | 21.92M | $1.07B | +1 | −2 |
| Q2 2025 | 17 | +1 | 20.74M | $1.55B | +1 | n/a |
| Q1 2025 | 13 | -1 | 9.03M | $573.92M | +1 | −2 |
| Q4 2024 | 14 | 0 | 9.30M | $726.05M | +1 | −1 |
| Q3 2024 | 13 | -3 | 7.86M | $631.67M | n/a | −3 |
| Q2 2024 | 16 | n/a | 7.65M | $633.10M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 6.02M | -5.4% | $293.45M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (被动) | 4.83M | -2.4% | $235.64M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | AQR Capital Management ✦ | 2.13M | +372.8% | $102.81M | 0.1% | ▲ Add | 6 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 1.80M | -4.4% | $87.77M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 5 | Fidelity (FMR) ✦ | 1.22M | +45.5% | $59.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 6 | Geode Capital Management ✦ (被动) | 1.20M | -3.3% | $58.66M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 773.18K | +1957.0% | $37.68M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Fisher Asset Management ✦ | 662.50K | -3.9% | $32.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 582.75K | n/a | $28.40M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 557.96K | n/a | $27.19M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 11 | Morgan Stanley ✦ | 520.80K | n/a | $25.38M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 12 | Marshall Wace ✦ | 463.81K | -10.1% | $22.61M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | T. Rowe Price ✦ | 362.70K | +0.3% | $17.68M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Wellington Management ✦ | 317.13K | -85.2% | $15.46M | 0.0% | ▼ Trim | 6 | SEC ↗ ×7 |
| 15 | Citadel Advisors ✦ | 221.43K | -12.3% | $10.79M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Arrowstreet Capital ✦ | 126.07K | 新增 | $6.14M | 0.0% | New | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 59.10K | +27.7% | $2.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 43.05K | -90.2% | $2.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 22.93K | +0.4% | $1.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $6.14M | 0.0% |
已清仓
| Norges Bank | $36.82M | 曾为 0.0% |
| Two Sigma Investments | $531,372 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 321 持有人, 47.04M 股份, $2.56B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据